Multimorbidity in Patients with Chronic Obstructive Pulmonary Disease
Copyright © 2020 Elsevier Inc. All rights reserved..
Chronic obstructive pulmonary disease (COPD) is a complex disease manifested primarily as airflow limitation that is partially reversible as confirmed by spirometry. COPD patients frequently develop systemic manifestations, such as skeletal muscle wasting and cachexia. COPD patients often develop other comorbid diseases, such as ischemic heart disease, heart failure, osteoporosis, anemia, lung cancer, and depression. Comorbidities complicate management of COPD and need to be evaluated because detection and treatment have important consequences. Novel approaches aimed at integrating the multiple morbidities seen in COPD and other chronic diseases will provide new avenues of research and allow developing more comprehensive and effective therapeutic approaches.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
---|---|
Enthalten in: |
Clinics in chest medicine - 41(2020), 3 vom: 29. Sept., Seite 405-419 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Divo, Miguel [VerfasserIn] |
---|
Links: |
---|
Themen: |
COPD comorbidities |
---|
Anmerkungen: |
Date Completed 10.11.2020 Date Revised 10.11.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.1016/j.ccm.2020.06.002 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM313748101 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM313748101 | ||
003 | DE-627 | ||
005 | 20231225151233.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ccm.2020.06.002 |2 doi | |
028 | 5 | 2 | |a pubmed24n1045.xml |
035 | |a (DE-627)NLM313748101 | ||
035 | |a (NLM)32800195 | ||
035 | |a (PII)S0272-5231(20)30035-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Divo, Miguel |e verfasserin |4 aut | |
245 | 1 | 0 | |a Multimorbidity in Patients with Chronic Obstructive Pulmonary Disease |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.11.2020 | ||
500 | |a Date Revised 10.11.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Elsevier Inc. All rights reserved. | ||
520 | |a Chronic obstructive pulmonary disease (COPD) is a complex disease manifested primarily as airflow limitation that is partially reversible as confirmed by spirometry. COPD patients frequently develop systemic manifestations, such as skeletal muscle wasting and cachexia. COPD patients often develop other comorbid diseases, such as ischemic heart disease, heart failure, osteoporosis, anemia, lung cancer, and depression. Comorbidities complicate management of COPD and need to be evaluated because detection and treatment have important consequences. Novel approaches aimed at integrating the multiple morbidities seen in COPD and other chronic diseases will provide new avenues of research and allow developing more comprehensive and effective therapeutic approaches | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a COPD comorbidities | |
650 | 4 | |a COPD system networks | |
650 | 4 | |a Multimorbidity | |
700 | 1 | |a Celli, Bartolome R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinics in chest medicine |d 1991 |g 41(2020), 3 vom: 29. Sept., Seite 405-419 |w (DE-627)NLM012973599 |x 1557-8216 |7 nnns |
773 | 1 | 8 | |g volume:41 |g year:2020 |g number:3 |g day:29 |g month:09 |g pages:405-419 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ccm.2020.06.002 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 41 |j 2020 |e 3 |b 29 |c 09 |h 405-419 |